相关实验视频
Updated: Jun 8, 2025
05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
在II期试验中使用一个基于实用性的规则进行贝叶斯安全性和徒劳性监测
1Department of Statistics, University of California, Santa Cruz, Santa Cruz, California.
Statistics in medicine
|November 5, 2024
概括
一种新的贝叶斯方法,U-Bayes,通过使用联合顺序结果而不是二分化数据来改进临床试验中的早期停止规则. 这种方法通过保留信息并考虑结果关联来加强治疗可接受性决策.
科学领域:
- 生物统计学 生物统计学
- 临床试验设计 临床试验设计
- 决策理论 决策理论
背景情况:
- 第二阶段临床试验通常将顺序毒性和响应数据进行二分,用于监测.
- 使用切割点的传统方法导致信息丢失和偏见的治疗可接受性决定.
- 现有的方法忽略了毒性和反应结果之间的关键关联.
研究的目的:
- 引入一种新的贝叶斯方法 (U-Bayes) 以在II期试验中更准确地评估治疗可接受性.
- 克服二分化在分析联合顺序结果方面的局限性.
- 制定一个早期停止规则,利用结果的完全联合分配.
主要方法:
- 提出了贝叶斯方法 (U-Bayes),使用联合顺序结果的引发的数值实用程序.
- 构建了一个单一的早期停止规则,该规则基于将平均效用与下限进行比较.
- 开发了一种逐步算法,用于U-Bayes规则构建,使用引发的实用程序和边际概率极限.
主要成果:
- 通过不二分序列结果,U-Bayes避免了信息丢失.
- 该方法考虑了毒性和反应之间的关联.
- 与传统设计相比,模拟研究表明U-Bayes显著提高了正确确定治疗可接受性的概率.
结论:
- U-Bayes为二期临床试验监测提供了比传统方法更好的替代方案.
- 贝叶斯方法通过利用顺序结果的完整联合分布来提高决策准确性.
- 这种方法为评估基于毒性和反应的实验性治疗提供了更强大的框架.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
01:09Censoring Survival Data
65
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
65
01:24Kaplan-Meier Approach
102
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
102
01:20Comparing the Survival Analysis of Two or More Groups
155
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
155
01:18Survival Curves
106
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
106
01:20Actuarial Approach
63
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
63